Novartis AG Vaccine Shields Against Meningitis Cause
6/9/2011 7:42:50 AM
Novartis AG's (NOVN.VX) Bexsero vaccine helps protect toddlers against the most common cause of meningitis when used as a booster, the Swiss drugmaker said on Thursday, giving its meningitis franchise another lift.
A late-stage study showed toddlers who had three doses as infants were protected against the meningococcal serogroup B, or MenB, when later given extra doses, cutting their risk of catching the potentially deadly illness.
comments powered by